Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06637332 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia

Study acronym: DAPTO-SNAP
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Jan 2027 → Jan 2029
See other at-risk trials from Todd C. Lee MD MPH FIDSA

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jan 2027 to Jan 2029
    • Study completion pushed from Nov 2027 to Nov 2029
    • Study sites: 19 to 20
    v15
  2. Study sites: 18 to 19v14
  3. Study sites: 17 to 18v13
  4. Study sites: 16 to 17v12
  5. Study sites: 15 to 16v11
Show 9 earlier versionsHide 9 earlier versions
  1. Study sites: 14 to 15v10
  2. Study sites: 13 to 14v9
  3. Site details revised at 4 of 13 sitesv8
  4. Study sites: 12 to 13v7
  5. Study sites: 2 to 12v6
  6. Study sites: 1 to 2v5
  7. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 2024 to Nov 14, 2024
    • Site details revised
    v4
  8. Site contact updatedv3
  9. Eligibility criteria shortened, about 6 wordsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is an open label randomized controlled trial for patients with methicillin resistant S. aureus (MRSA) bloodstream infection which will directly compare the two most commonly used therapies, vancomycin and daptomycin. This study is an approved sub-study of The Staphylococcus aureus Network Adaptive Platform (SNAP) trial (NCT05137119)
Trial Details
NCT Number NCT06637332
Lead Sponsor Todd C. Lee MD MPH FIDSA
Collaborators: University of Melbourne, The Peter Doherty Institute for Infection and Immunity
Conditions
(from sponsor)		 Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia, S. Aureus Bacteremia, S. Aureus Bloodstream Infection, Staphylococcus Aureus Endocarditis
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov